HOME >> MEDICINE >> NEWS
GroPep licenses technology to TGR BioSciences

GroPep announced today it has licensed its Whey Growth Factor Extract (WGFE) technology to Australian biotechnology company, TGR BioSciences (TGR).

TGR has raised $3 million to fund further clinical development of WGFE as a treatment for oral mucositis, a debilitating side effect of cancer treatments.

GroPep will receive royalties of more than 10% on TGR's commercialisation of the technology.

Biopharmaceutical company GroPep Limited (ASX: GRO) today announced that it has licensed certain Whey Growth Factor Extract (WGFE) technology rights to TGR BioSciences Pty Ltd (TGR). This arrangement will also allow TGR to raise additional funds to finance further development of the technology.

Under two separate agreements, venture capitalist Nanyang Innovation Fund managed by Nanyang Ventures (Nanyang) will invest up to $3 million, TGR will start a clinical trial of WGFE for oral mucositis and GroPep will license the WGFE technology to TGR.

GroPep will receive royalties of more than 10% from TGR on commercialisation of the technology and TGR has taken over responsibility for five patent families developed by GroPep and the related costs. GroPep's shareholding in TGR is reduced from 20% to 12%.

Among the rights licensed to TGR is GroPep's oral mucositis product technology. Oral mucositis is an extremely painful side effect afflicting chemotherapy patients. GroPep and collaborators have previously generated significant preclinical and clinical data, including a successful Phase 1b trial conducted at the Peter MacCallum Cancer Centre in Melbourne, indicating the safety and potential for WGFE to treat this condition. TGR has committed to initiate further clinical development in the oral mucositis setting within the next year.

Mr Gregory Moss-Smith, Vice President of Commercial Operations at GroPep, said "Licensing the technology to TGR, combined with the capital injection from Nanyang, is an effective means of advancing
'"/>

Contact: Tony Mitchell
investorrelations@gropep.com.au
61-883-547-700
Research Australia
26-Jul-2005


Page: 1 2

Related medicine news :

1. GroPep awarded key patent for infertility treatment in Europe
2. GroPep starts Phase 1 infertility trial
3. GroPep completes final milestone of the path malaria vaccine initiative
4. GroPep to pursue promising asthma drug following preclinical study results
5. GroPep news: Key psoriasis patent granted in Japan and new asthma patent filed for GroPep drug
6. Doctors working overseas face having licenses removed
7. UW licenses innovated cardiovascular software to VPDiagnostics
8. The Wistar Institute licenses rubella vaccine seed stock to Microgen of Russia
9. MCW Research Foundation licenses invention for stroke treatment
10. Wireless technology shows promise in diagnosing pediatric intestinal disease
11. Speeding up CT scans with cellphone technology, ultrasound warning signal for breast cancer

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/21/2020)... ... ... Dr. Stong, a leading Atlanta facial plastic and reconstructive surgeon , ... volunteer with Healing the Children (HTC) , traveling to locations abroad to assist ... lip and palate procedures to underprivileged pediatric patients in the area of Ica, Peru. ...
(Date:2/21/2020)... ... February 21, 2020 , ... Cosmetic surgery continues to ... of Plastic Surgeons (ASPS). According to the ASPS, there were 17.7-million cosmetic procedures ... the previous year. The American Society of Plastic Surgeons reported that some of ...
(Date:2/20/2020)... ... February 20, 2020 , ... R3 Stem Cell, the ... able to complete 70 complimentary stem cell procedures on military veterans in ... at no cost. , At the R3 Stem Cell Training Course for doctors , ...
(Date:2/19/2020)... ... February 19, 2020 , ... Drs. Richard Amato, Michael Kang, ... Connecticut, celebrate 30 years of serving Monroe, CT with a “Throwback Special” where ... charged in 1989, only thirty dollars. To further serve their patients, they published ...
(Date:2/19/2020)... ... 19, 2020 , ... In 2017, the EU’s revamped Medical ... that currently govern medical device manufacturers under the Medical Devices Directive (MDD); the ... Major changes from the previous MDD include:, , Elimination ...
Breaking Medicine News(10 mins):
(Date:2/20/2020)... ... February 20, 2020 , ... Amada Senior Care ... in-home senior care from trained and knowledgeable Amada caregivers. From day one of ... meeting every client’s unique needs, preferences and desires, all with the goal of ...
(Date:2/20/2020)... (PRWEB) , ... February 20, 2020 , ... ... Resort, 6333 North Scottsdale Road, in Arizona, will be a timely and relevant ... relevant, practical instruction in the management of chronic pain. , In 2020, paper ...
(Date:2/19/2020)... ... ... Aspire Regenerative, a leader in offering therapies that restore healthy tissues in the ... on March 1, 2020. It will take place from 10:30 a.m. to 1:30 p.m. ... event, physicians and pharmacists will lead an informative and insightful discussion on weight loss. ...
Breaking Medicine Technology:
Cached News: